Research Article

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients

Table 2

Frequencies of Tc17 and Tc1 in peripheral blood and gut-associated lymphoid tissue (GALT) samples collected from HIV-1-infected patients () who achieved virological suppression in response to ART therapy.

Frequencies GALTPeripheral blood values

Tc17 cells (median/range)0.21/0.00–1.500.03/0.00–0.1
Tc1 cells (median/range)10.59/0.32–56.340.36/0.0–58.24
CD8+ DP T cells (median/range) 0.095/0.0–1.160.005/0.0–0.11
Naïve Tc17 cells (median/range)0.17/0.0–1.90.11/0.0–0.27
Naïve Tc1 cells (median/range)6.24/0.37–41.740.49/0.0–31.61
Naïve CD8+ DP T cells (median/range)0.0/0.0–0.410.01/0.0–0.07
Central memory Tc17 cells (median/range) 0.16/0.0–1.47 0.05/0.00–0.51
Central memory Tc1 cells (median/range)15.38/0.52–58.751.36/0.0–72.9
Central memory CD8+ DP T cells (median/range)0.09/0.0–1.170.04/0.0–1.17
Effector memory Tc17 cells (median/range) 0.14/0.0–1.640.025/0.00–0.09
Effector memory Tc1 cells (median/range)10.27/0.270.45/0.0–83.54
Effector memory CD8+ DP T cells (median/range)0.00/0.0–1.240.00/0.00–1.64

Wilcoxon test was used to compare Tc17 and Tc1 frequencies in peripheral blood and GALT. Significant values are highlighted in bold.